Is Krsnaa Diagnostics Limited a good investment? Krsnaa Diagnostics Limited (KRSNAA.NS) is currently trading at 533.30 INR. Market analysts have a consensus price target of 841.00 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 17.99. This valuation is generally in line with the broader market.
Earnings Schedule: Krsnaa Diagnostics Limited is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 46.30.
For income investors, Krsnaa Diagnostics Limited pays a dividend yield of 0.38%. With a payout ratio of 1%, the dividend appears sustainable.
Yes, it pays an annual dividend of 2.00 INR (0.38% yield).
Krsnaa Diagnostics Limited is classified as a Stock.
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 29.65.
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services. The company was incorporated in 2010 and is based in Pune, India.
| Year | Total Dividends |
|---|---|
| ▸2026 |
2.00 INR
|
| Oct. 28, 2026 | 2.0000 |
| ▸2025 |
2.75 INR
|
| Oct. 25, 2025 | 2.7500 |
| ▸2024 |
2.50 INR
|
| Oct. 21, 2024 | 2.5000 |
| ▸2023 |
2.75 INR
|
| Sept. 15, 2023 | 2.7500 |
| ▸2022 |
2.50 INR
|
| Sept. 15, 2022 | 2.5000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Krsnaa Diagnostics Limited | Oct 28, 2026 | Upcoming | 2.0 INR |
Community Discussion